✦ LIBER ✦

Treatment of patients with advanced ovarian cancer (FIGO IIb-IV) with cisplatin/paclitaxel or carboplatin/paclitaxel — An interim analysis of the ago study protocol ovar-3

✍ Scribed by W. Schröder; A. du Bois; W. Kuhn; H.J. Lück; V. Möbus; W. Meier; U. Nitz; S. Olbricht; J. Pfisterer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin/paclitaxel vs. carboplatin/pac

✍ Costa, S.D.; du Bois, A.; Lueck, H.J.; Meier, W.; Moebus, V.; Bauknecht, T.; Ric 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 197 KB

A phase II study of paclitaxel, carbopla

✍ A. du Bois; A. Belau; U. Wagner; J. Pfisterer; B. Schmalfeldt; B. Richter; A. St 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 302 KB

First-line treatment of ovarian/tubal/pe

✍ G.B. KRISTENSEN; I. VERGOTE; G. STUART; J.M. Del CAMPO; J. KÆRN; M. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB

172 Phase I/II study of PLD and carbopla

✍ V. Heilmann; A. Burges; M. Gropp; J. Pfisterer; B. Schmalfeldt; B. Richter; Ch. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB